<p>Adverse events leading to change or discontinuation of itraconazole therapy for both Group A and B patients.</p
<p>Categorisation of adverse events reported in the placebo and melatonin treatment groups.</p
<p>Abbreviations: A/E (adverse effects), TCZ (tocilizumab), IFX (infliximab), ETN (etanercept), ADA ...
<p>Treatment-emergent adverse events experienced by ≥5% of patients in either treatment group (treat...
<p>Adverse events leading to change or discontinuation of voriconazole therapy for both Group A and ...
Treatment-emergent adverse events occurring in ≥ 5% of patients in the etelcalcetide arms, adverse e...
<p>Group A: 10-day esomeprazole/amoxicillin/levofloxacin triple therapy;</p><p>Group B: 14-day esome...
<p>M-H = Mantel-Haenszel method; CI = confidence interval. CTCAE: Common Terminology Criteria for Ad...
To compare the frequency and risk factors of toxicity-related treatment discontinuations between ral...
Suspected adverse reactions to antifungal drugs requiring change to or withholding of treatment.</p
<p>Treatment-emergent adverse events occurring during the Phase I study in at least two different su...
Showing the number of patients discontinuing therapy and the primary documented causes by drug group...
<p>Treatment-emergent adverse events experienced by ≥3 patients in any treatment group in the Phase ...
<p>Adverse events of any severity in the different treatment groups in The Gambia.</p
<p>Adverse events between more intensive and less intensive BP lowering regimen.</p
Comment on Tolerance of benznidazole in a United States Chagas Disease clinic. [Clin Infect Dis. 201...
<p>Categorisation of adverse events reported in the placebo and melatonin treatment groups.</p
<p>Abbreviations: A/E (adverse effects), TCZ (tocilizumab), IFX (infliximab), ETN (etanercept), ADA ...
<p>Treatment-emergent adverse events experienced by ≥5% of patients in either treatment group (treat...
<p>Adverse events leading to change or discontinuation of voriconazole therapy for both Group A and ...
Treatment-emergent adverse events occurring in ≥ 5% of patients in the etelcalcetide arms, adverse e...
<p>Group A: 10-day esomeprazole/amoxicillin/levofloxacin triple therapy;</p><p>Group B: 14-day esome...
<p>M-H = Mantel-Haenszel method; CI = confidence interval. CTCAE: Common Terminology Criteria for Ad...
To compare the frequency and risk factors of toxicity-related treatment discontinuations between ral...
Suspected adverse reactions to antifungal drugs requiring change to or withholding of treatment.</p
<p>Treatment-emergent adverse events occurring during the Phase I study in at least two different su...
Showing the number of patients discontinuing therapy and the primary documented causes by drug group...
<p>Treatment-emergent adverse events experienced by ≥3 patients in any treatment group in the Phase ...
<p>Adverse events of any severity in the different treatment groups in The Gambia.</p
<p>Adverse events between more intensive and less intensive BP lowering regimen.</p
Comment on Tolerance of benznidazole in a United States Chagas Disease clinic. [Clin Infect Dis. 201...
<p>Categorisation of adverse events reported in the placebo and melatonin treatment groups.</p
<p>Abbreviations: A/E (adverse effects), TCZ (tocilizumab), IFX (infliximab), ETN (etanercept), ADA ...
<p>Treatment-emergent adverse events experienced by ≥5% of patients in either treatment group (treat...